Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Pulmonary Fibrosis”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableLooking for participantsNCT07269262
What this trial is testing

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
Medical University of South Carolina 170
Not applicableLooking for participantsNCT06644144
What this trial is testing

P4O2 ILD Extension

Who this might be right for
Interstitial Lung DiseasePulmonary FibrosisInterstitial Lung Fibrosis+7 more
Amsterdam UMC, location VUmc 450
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Large-scale testing (Phase 3)Looking for participantsNCT05828953
What this trial is testing

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Who this might be right for
Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07503587
What this trial is testing

Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis

Who this might be right for
Progressive Pulmonary Fibrosis
Haisco Pharmaceutical Group Co., Ltd. 378
Not applicableStudy completedNCT04702893
What this trial is testing

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 108
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Early research (Phase 1)Looking for participantsNCT06821464
What this trial is testing

A Trial of HRS-9813 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 60
Not applicableLooking for participantsNCT06162884
What this trial is testing

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of California, Los Angeles 200
Not applicableLooking for participantsNCT06251687
What this trial is testing

Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisTransbronchial Cryobiopsy
China-Japan Friendship Hospital 100
Early research (Phase 1)Ended earlyNCT05644600
What this trial is testing

Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Who this might be right for
Healthy Subjects
AstraZeneca 18
Not applicableLooking for participantsNCT07486206
What this trial is testing

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Who this might be right for
Interstitial Lung Disease (ILD)Fibrotic Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis (IPF)+2 more
Hospital de Granollers 152
Not applicableStudy completedNCT04857814
What this trial is testing

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases

Who this might be right for
Progressive Fibrosing Interstitial Lung DiseaseLung TransplantCystic Fibrosis+2 more
University of Alberta 8
Post-approval studies (Phase 4)UnknownNCT03260556
What this trial is testing

Pirfenidone for Progressive Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
University of Cincinnati 60
Not applicableUnknownNCT06275295
What this trial is testing

A Retrospective Study of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisTransbronchial Cryobiopsy
China-Japan Friendship Hospital 300
Large-scale testing (Phase 3)Enrolling By InvitationNCT04905693
What this trial is testing

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis
United Therapeutics 1,850
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110
Not applicableLooking for participantsNCT06855329
What this trial is testing

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
University of Massachusetts, Worcester 500
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Load More Results